Skip to content
★ Sign in to follow
PS

Professor Sir Roy Anderson

GlaxoSmithKline plc
Total declarations
8
Company
1
▲ Purchases (7 ops.)
€59k
▼ Sales (0 ops.)
—

Latest filing published 09 May 2018 for GlaxoSmithKline plc, €8,229.

Filing timeline

BuySale
Professor Sir Roy Anderson

Insider track record

Disclosed buys
7
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
7

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Professor Sir Roy Anderson: trading record in brief

Professor Sir Roy Anderson discloses dealings in GlaxoSmithKline plc to RNS (LSE). Between 26 October 2016 and 25 April 2018, the trades on record add up to 8 filings.

On the market, this insider has only ever bought: 7 purchases, €59k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant. In 2018 alone, the filings show 2 purchases and no sales.

In size, the median ticket on the buying side is €8,229.

The latest filing, published on 9 May 2018, reports an open-market purchase of €8,229 in GlaxoSmithKline plc. Between a trade and the moment it shows up on RNS (LSE), the median delay is 1 day. The legal deadline for notifying a trade is three business days (UK MAR). Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Professor Sir Roy Anderson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total
  • ▲
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    7,188 GBP0FCA-NSM
    497.405 shares@ £14.458.8% of flown/aISIN GB0009252882FCA-NSM:LSE20180509170556_13635247_20200330111432016_18707-1
    Canonical exit: 24 Jul 2018 (T+90)
  • ▲
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    7,188 GBP0FCA-NSM
    562.402 shares@ £12.7810.8% of flown/aISIN GB0009252882FCA-NSM:LSE20180207131918_13525081_20200330111413524_21321-1
    Canonical exit: 8 May 2018 (T+90)
  • ▲
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    7,188 GBP0FCA-NSM
    473.485 shares@ £15.1810.8% of flown/aISIN GB0009252882FCA-NSM:LSE20171025152118_13409025_20200330131538139_17441-1
    Canonical exit: 23 Jan 2018 (T+90)
  • ▲
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    9,062 GBP0FCA-NSM
    566.76 shares@ £15.9911.9% of flown/aISIN GB0009252882FCA-NSM:LSE20170726132247_13308370_20200330131517640_18500-1
    Canonical exit: 24 Oct 2017 (T+90)
  • ▲
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    7,188 GBP0FCA-NSM
    454.043 shares@ £15.8311.3% of flown/aISIN GB0009252882FCA-NSM:LSE20170427174026_13207549_20200330131501285_19100-1
    Canonical exit: 25 Jul 2017 (T+90)
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    28,770 GBP12FCA-NSM
    1,850.161 shares@ £15.5545.0% of flown/aISIN GB0009252882FCA-NSM:LSE20170209173222_13123567_20200330131513749_6702-1
  • ▲
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    7,188 GBP0FCA-NSM
    462.219 shares@ £15.5511.2% of flown/aISIN GB0009252882FCA-NSM:LSE20170209134215_13122809_20200330131513733_6248-1
    Canonical exit: 9 May 2017 (T+90)
  • ▲
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    7,188 GBP0FCA-NSM
    437.462 shares@ £16.4310.8% of flown/aISIN GB0009252882FCA-NSM:LSE20161026171005_013014274_20200330143616712_19788-1
    Canonical exit: 24 Jan 2017 (T+90)

8 of 8 declarations